Litcius/Paper detail

A 300 IR sublingual tablet is an effective, safe treatment for house dust mite–induced allergic rhinitis: An international, double-blind, placebo-controlled, randomized phase III clinical trial

Pascal Demoly, Jonathan Corren, Peter S. Creticos, F. de Blay, Philippe Gevaert, Peter W. Hellings, Krzysztof Kowal, Martine Le Gall, Natalia Nenasheva, Giovanni Passalacqua, Oliver Pfaar, Miguel Tortajada‐Girbés, Carmen Vidal, Margitta Worm, Thomas B. Casale

2020Journal of Allergy and Clinical Immunology95 citationsDOIOpen Access PDF

Topics & Concepts

House dust miteDouble blindPlaceboMedicineSublingual immunotherapyDermatologyAnesthesiaAllergyRandomized controlled trialAllergenInternal medicineImmunologyPathologyAlternative medicineAllergic Rhinitis and SensitizationAsthma and respiratory diseasesOlfactory and Sensory Function Studies
A 300 IR sublingual tablet is an effective, safe treatment for house dust mite–induced allergic rhinitis: An international, double-blind, placebo-controlled, randomized phase III clinical trial | Litcius